Transcriptional activators need to be modulated and eventually switched off after the initial event that triggers their activation. Here, we discuss how ubiquitination of activators and their proteasome-mediated turnover are crucial steps in this process.
Transcriptional activators bind to specific sites in the promoter of target genes and subsequently stimulate various events in the transcription cycle. In most cases, activators are present in an inactive form that is then switched on in response to one or more signaling events. These triggering mechanisms include posttranslational modification of the activator itself (or the proteins that hold it in the inactive state), allosteric mechanisms that disrupt the interactions between activators and inhibitors, and changes in subcellular localization. Although the details of these triggering processes are of keen interest to biologists, significant attention has only recently been focused on how the activity of an activator is limited and eventually switched off. Ensuring that ongoing transcription of an inducible gene is tied to continued signaling is critical to maintaining appropriate homeostasis in cells. Therefore, deactivation of activators is presumably also a tightly regulated process, but what are the underlying mechanisms behind this process?
Transcription-Factor Ubiquitination and Turnover An obvious mechanism to limit the time that an activator works is to destroy it via the ubiquitin-proteasome pathway. Ideally, activator turnover should be tied to its ability to drive transcription. Over the last few years, evidence has emerged that this is indeed the case in some systems (Muratani and Tansey, 2003) . For example, in mammalian cells, the levels of proteins that are fused to the Gal4 activation domain show an inverse correlation with their potency as activators (Molinari et al., 1999) . Furthermore, the domains of several activators required for turnover via the ubiquitin-proteasome pathway (called a degron) correspond closely to the activation domains of these proteins. Degrons derived from yeast cyclins work as transcriptional activation domains when fused to a DNA-binding domain. In addition, the F box protein Skp2, an E3 ubiquitin ligase, not only regulates the stability of Myc in vivo but also acts as a cofactor that is essential for full activity of Myc (Muratani and Tansey, 2003) .
Chromatin immunoprecipitation (ChIP) analysis of transcription factor-DNA interactions at an estrogen receptor α (ER-α)-regulated promoter has yielded valuable insights (Reid et al., 2003) . These studies confirmed previous reports showing that proteasome activity was essential for high-level activation of ER-α-regulated genes and showed that chemical inhibition of the proteasome resulted in the buildup of polyubiquitinated ER-α. Remarkably, ChIP assays revealed that the activator ER-α (bound to its ligand) cycled on and off the promoter with a periodicity of ≈45 min and that various other transcription factors-including polymerase components, general transcription factors, coactivators, and AAA ATPases-also cycled with a periodicity similar to ER-α but with a different phase. This is consistent with waves of assembly and disassembly of ER-α-dependent transcription complexes on the promoter. When proteasome activity was blocked, this cycling was abrogated. These data indicate that proteasome-mediated proteolysis is essential for disassembly of transcription complexes during these waves of complex formation and dissolution.
What is the mechanistic basis of this coupling between activation and proteasome-mediated turnover? The answer may lie in the ubiquitination state of the activator. The first such indication was that deletion of the gene encoding the E3 ubiquitin ligase Met30 not only increased levels of the artificial activator LexA-VP16 but crippled its ability to activate target genes (Salghetti et al., 2001) . Again, this is consistent with coupled activation and turnover. This study's remarkable finding was that the introduction of a construct encoding a single ubiquitin molecule fused to LexA-VP16 (Ub-LexA-VP16) into cultured cells lacking Met30 resulted in significant restoration of LexA-responsive reporter-gene transcription. Transcription occurs even though the amount of the Ub-LexA-VP16 fusion protein remained high, indicating that it was not subject to efficient proteolysis. This result suggested that activator monoubiquitination is a key modification that promotes the activity of the activator. Notably, monoubiquitination of a protein does not signal
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Thomas Kodadek, 1, * Devanjan Sikder, 1 and Kip Nalley 1 its proteasome-mediated degradation, which requires chains of at least four K48-linked ubiquitin molecules (Thrower et al., 2000) . Why does monoubiquitination of an activator stimulate its activity? This question is only beginning to be addressed. A ubiquitination-dependent increase in recruitment of P-TEFb, an important elongation factor, by LexA-VP16 has been reported (Kurosu and Peterlin, 2004) . The efficiency of posttranscriptional processes also may be stimulated by activator ubiquitination (Muratani et al., 2005) . The effects of activator monoubiquitination on earlier steps in the gene expression cycle are unknown.
Timers and Black Widows
Several investigators have synthesized the available data to propose models that intimately link activator potency, ubiquitination, and proteasome activity. These have been dubbed "timer" (Conaway et al., 2002; Gonzalez et al., 2002) or "black widow" (Muratani and Tansey, 2003) mechanisms (see Figure  1 ). The timer model assumes that activator monoubiquitination is a necessary licensing event for high-level gene expression and that extension of this modification into a K48-linked polyubiquitin chain would occur subsequently. As stated above, at least four ubiquitin molecules must be added to a protein to allow it to be recognized as a proteasome substrate (Thrower et al., 2000) . Therefore, the activator would have the time required to go from one to four or more ubiquitins in which to drive gene expression, after which it would be destroyed by the proteasome. The black widow model also proposes a window of activity but specifically suggests that activator polyubiquitination and subsequent destruction is a necessary consequence of "mating" with the polymerase holoenzyme. This model incorporates the findings of an elegant study on the turnover of the yeast activator Gcn4 (Chi et al., 2001) , in which it was shown that the Srb10 kinase phosphorylates Gcn4 and that this triggers subsequent polyubiquitination by the ubiquitin ligase complex SCF Cdc4 . It is often the case that phosphorylation triggers subsequent ubiquitination. Srb10 is a component of the Mediator complex that associates with the C-terminal domain of the largest subunit of RNA polymerase II. Thus, by carrying out a central function of an activator (the recruitment of the Mediator complex and hence RNA polymerase II), Gcn4 is presented to the protein kinase that triggers its destruction.
An interesting consequence of the observed requirement for proteasome-mediated turnover of at least some activators in the context of these models is that one is forced to speculate that the polyubiquitinated protein is much less active than the monoubiquitinated form. Otherwise, in the absence of proteolysis, the polyubiquitinated form of the activator would simply build up over time, and gene expression would continue unabated. As this is not the case, it might be that, when the activator (or perhaps some other transcription protein) is polyubiquitinated, it loses activity and, unless cleared by the proteasome, "gums up the works." Why a polyubiquitinated activator would be less active than the monoubiquitinated form is unknown, but the important point is that, rather than being essential for activation per se, proteasome-mediated degradation may be required to eliminate an "exhausted" form of the activator that would otherwise act as a competitive inhibitor of fresh activator. This viewpoint may help to resolve some of the apparent contradictions to the intimate Two models for understanding the role of posttranslational modifications and proteasome-mediated degradation of activators in regulating their activity are shown. In the "black widow" model, recruitment of the transcription complex (PIC, preinitiation complex) to the promoter results in the phosphorylation and ubiquitination of the activator. These modifications, which eventually trigger activator destruction, are contained within the transcription complex. The secondgeneration timer model is a modification of the timer and black widow models. For clarity, only the activator is shown. In this model, it is proposed that only the monoubiquitinated form of the activator is competent to drive transcription. The ubiquitinated state of the activator is controlled by ubiquitin ligases and deubiquitinases and potentially by kinases and phosphatases. See text for details.
connection of transcription and proteasome-mediated proteolysis discussed below.
The timer and black widow models are immensely appealing in providing a mechanism to couple the licensing of a transcriptional activator through monoubiquitination, which may be preceded by phosphorylation, to its subsequent destruction. Nonetheless, there are already data in the literature that argue that this mechanism is not general for all inducible activators. For example, the glucocorticoid receptor does not require proteasome activity to drive gene expression and is an extremely long-lived protein that must be deactivated by nonproteolytic mechanisms (Hager et al., 2004) . The activity of the heat-shock factor (HSF) is strongly stimulated by proteasome inhibition and, moreover, HSF forms longlived complexes on native promoters that do not cycle in an ER-α-like fashion (Yao et al., 2006) . A recent report using a novel variant of the chromatin precipitation assay capable of monitoring the lifetime of activator-promoter complexes argues that this is also true for the yeast activator Gal4 (Nalley et al., 2006) , though there are conflicting reports (Lipford et al., 2005; Muratani et al., 2005) . Even in the case of ER-α, mutations at a single residue (S118) can uncouple activator potency and proteasomemediated turnover, showing that these are mechanistically separable functions (Valley et al., 2005) .
A Second-Generation Timer Model
Is it possible to reconcile all of the apparently disparate findings described above into a cohesive model for regulating activator potency and the longevity of activator-promoter complexes? Although the answer is not clear, the second-generation timer model shown in Figure 1 attempts to do so. This model focuses on the monoubiquitinated (and probably phosphorylated) activator as the intermediate of central importance and acknowledges the fact that monoubiquitination and subsequent extension into a polyubiquitin chain are two completely different chemical events. These events can occur at different rates or even be mediated by different ubiquitin ligases, with the chain extenders sometimes referred to as E4 ligases. Furthermore, deubiquitinases (DUBs) are invoked as a potential mechanism to antagonize chain growth or even to reverse the monoubiquitination event. Finally, as mentioned above, it assumes that the polyubiquitinated activator is poorly active for reasons unknown.
In this view, if chain extension is efficient, the active period for the licensed (monoubiquitinated) activator would be short and proteasome activity would be critical to remove the inactive, polyubiquitinated molecule from the system and open the promoter to "fresh" transcription factor. However, if chain extension were slow due to poor activity of an E4 ligase or potent antagonism of extension by a DUB, the licensed activator could function for a considerable period of time, the activator-promoter complex would be long lived, and proteasome activity would be less important. Given that different E3 and E4 ligases and DUBs presumably work on different transcriptional activators, it seems reasonable to assume that the relative rates of these events can vary widely for different activators. Furthermore, as these modifying enzymes must bind to their substrates, it suggests how specific mutations in the activator could easily alter the relative rates of mono-and polyubiquitination or DUBcatalyzed chain shortening, thus apparently uncoupling activation potency and proteasome-mediated turnover, as was observed for mutations at S118 in ER-α. Finally, invoking the activity of DUBs (and probably also phosphatases) in the regulation of activator potency provides a simple mechanism for shutting off a transcriptional switch completely without the requirement for activator proteolysis.
Clearly, this model raises as many questions as it answers. What are the relative rates of mono-and polyubiquitination for a given activator, and how are they regulated? Do these events even involve the same lysine residue? Do DUBs indeed recognize ubiquitinated activators as substrates? If so, how are opposing E3 or E4 ubiquitin ligases and DUB activities balanced? How can we more efficiently match activators with the modifying enzymes that operate on them? Why would a monoubiquitinated activator be more potent than one bearing a polyubiquitin chain? Nevertheless, it may provide a useful framework for developing experiments to probe these complex systems.
The Tortoise and the Hare A final point that is highly relevant to thinking about the dynamics of transcription-factor function is that the relatively slow cycling events of the type reported for ER-α transcription complexes (t 1/2 ≈ 45 min) may be overlaid on top of far more rapid activator-promoter association and dissociation events. A highly expressed gene fires once every few seconds. Do activator-promoter complexes survive multiple rounds of transcription, or do they dissociate after every round (or even more frequently)? Techniques such as standard ChIP analysis, DNase I footprinting, and the like provide a time-averaged view of DNA-protein interactions and would not be expected to reveal rapid, reversible association and dissociation. Fluorescence recovery after photobleaching (FRAP) is a useful technique to probe rapid equilibria. In this experiment, one employs cells that express a large amount of an activator-GFP fusion protein and contain an artificial promoter containing hundreds of activator binding sites. When the fluorescently tagged activator binds to these sites, it creates a microscopically observable fluorescent dot. When irradiated with a focused, high-powered laser beam, the GFP chromophores in this dot can be photobleached rapidly without affecting fusion protein elsewhere in the cell. One can then watch how long it takes for the dot to be reformed, which is a reflection of the amount of time required for the bleached fusion protein to dissociate and be replaced by fluorescent molecules from the large pool of unbound activator-GFP fusion protein.
Studies of GFP fusions of the glucocorticoid receptor by this technique have revealed highly dynamic activator-DNA complexes with a half-life of a few seconds, which is on the order of the frequency of the rate of gene transcription (Hager et al., 2004) . If this measurement truly reflects the kinetic stability of the activator-DNA complexes in cells, it suggests that they are being actively dissociated by chaperones (Freeman and Yamamoto, 2002) or chromatin-remodeling complexes (Hager et al., 2004) because the intrinsic dissociation rates of the protein-DNA complexes are much longer.
It is fair to ask whether these short timescale dynamics really matter in the larger picture of regulating gene expression. Put another way, how long must an activator remain resident on a promoter to drive transcription, and, if this time is increased, does it lead to more potent activation? The jury is still out on this point, but a recent study by Setzer and colleagues (Brady et al., 2005) suggests that the answer to the second question might be yes. In a study of different mutations of the RNA polymerase III activator TFIIIA that affected the stability of the protein-DNA complex, they found that the ability of the mutant proteins to activate transcription in yeast correlated with the kinetic dissociation constant rather than the equilibrium binding constant.
Finally, it is important to remember that not all activator-promoter complexes are so dynamic. As mentioned above, there is clear evidence for stable activator-promoter complexes such as those formed by HSF (Yao et al., 2006) or Gal4 (Nalley et al., 2006) , which apparently are not subject to, or can resist, this constant antagonism.
Conclusion
In conclusion, there has been an explosion of interest in the mechanisms employed to keep activators under control once they are induced. The data currently available suggest that both rapid (timescale of seconds) and slower (timescale of many minutes) mechanisms that modulate the stability of promoter-bound transcription complexes exist. Some of these mechanisms clearly involve the proteasome; some do not and instead are the result of active remodeling by ATP-dependent proteins. Different activators employ these various mechanisms to different extents, leading to a wide spectrum of dynamic behaviors of activator-promoter complexes within cells. Deciphering how all of these different processes are regulated and balanced is clearly critical to understanding the process of gene expression and should provide an interesting challenge for years to come.
